HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
Current candidate vaccines fail to protect primates against challenge with human immunodeficiency virus (HIV) in the presence of antibody responses; this underlines the importance of studying cell-mediated immunity to HIV and identifying specific epitopes that stimulate cytotoxic T lymphocytes (CTL)...
Autors principals: | Nixon, D, Townsend, A, Elvin, J, Rizza, C, Gallwey, J, Mcmichael, A |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
1988
|
Ítems similars
-
HIV-gag-specific cytotoxic T lymphocytes.
per: Nixon, D, et al.
Publicat: (1989) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
per: Townsend, A, et al.
Publicat: (1986) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
per: Townsend, A, et al.
Publicat: (1986) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986.
per: Townsend, A, et al.
Publicat: (2006) -
Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
per: Dorrell, L, et al.
Publicat: (2000)